ALGERT GLOBAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$437,000
+75.5%
12,920
+50.1%
0.03%
+36.8%
Q2 2022$249,000
+13.7%
8,608
+27.0%
0.02%
+35.7%
Q1 2022$219,000
+3.3%
6,778
-14.8%
0.01%
-50.0%
Q3 2021$212,000
-53.2%
7,955
-58.3%
0.03%
-79.3%
Q4 2019$453,000
-61.8%
19,090
-55.7%
0.14%
-69.5%
Q3 2019$1,185,000
+61.2%
43,123
+94.2%
0.44%
+62.5%
Q2 2019$735,000
+11.9%
22,210
+18.4%
0.27%
-27.5%
Q1 2019$657,000
-22.1%
18,758
-26.0%
0.38%
+59.6%
Q4 2018$843,000
+107.6%
25,363
+214.6%
0.24%
+167.0%
Q3 2018$406,000
-15.8%
8,0610.0%0.09%
-12.0%
Q2 2018$482,000
-90.5%
8,061
-92.7%
0.10%
-89.9%
Q1 2018$5,092,000
+91.1%
111,183
+66.3%
0.99%
+56.8%
Q4 2017$2,664,000
+6.3%
66,863
+6.7%
0.63%
+9.8%
Q3 2017$2,507,000
+12.4%
62,681
+21.1%
0.57%
-8.5%
Q2 2017$2,231,000
+21.6%
51,767
-11.7%
0.63%
+26.2%
Q1 2017$1,835,00058,6120.50%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders